两名转移性黑色素瘤肾移植患者使用伊匹单抗治疗成功。 - Suppr

Suppr

超能文献

Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.

作者信息

Lipson Evan J, Bodell Mabel A, Kraus Edward S, Sharfman William H

机构信息

Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

出版信息

J Clin Oncol. 2014 Jul 1;32(19):e69-71. doi: 10.1200/JCO.2013.49.2314. Epub 2014 Feb 3.

DOI:10.1200/JCO.2013.49.2314

PMID:24493726

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4870592/

Abstract

摘要

相似文献

Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.

J Clin Oncol. 2014 Jul 1;32(19):e69-71. doi: 10.1200/JCO.2013.49.2314. Epub 2014 Feb 3.

What is the role of chemotherapy in the treatment of melanoma?

Curr Treat Options Oncol. 2014 Jun;15(2):321-35. doi: 10.1007/s11864-014-0277-5.

Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma.

Oncol Res Treat. 2014;37(12):757-60. doi: 10.1159/000368316. Epub 2014 Oct 30.

Ipilimumab in cancer patients: the issue of early metabolic response.

Anticancer Drugs. 2013 Mar;24(3):324-6. doi: 10.1097/CAD.0b013e32835dbaaf.

[Metastatic malignant melanoma. Successfull treatment with ipilimumab].

Hautarzt. 2013 Apr;64(4):228, 230-1. doi: 10.1007/s00105-013-2557-6.

Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient.

Eur J Cancer. 2016 Nov;67:66-72. doi: 10.1016/j.ejca.2016.07.026. Epub 2016 Sep 8.

Unusual diffuse liver F-FDG uptake in melanoma patient treated by ipilimumab.

Hell J Nucl Med. 2017 May-Aug;20(2):179-181. doi: 10.1967/s002449910562. Epub 2017 Jul 12.

Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.

J Clin Oncol. 2015 Jun 10;33(17):1873-7. doi: 10.1200/JCO.2014.60.1807. Epub 2015 May 11.

Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases.

Clin Exp Dermatol. 2013 Apr;38(3):276-9. doi: 10.1111/j.1365-2230.2012.04452.x. Epub 2012 Oct 1.

Vemurafenib as neoadjuvant treatment for unresectable regional metastatic melanoma.

J Clin Oncol. 2013 Jun 1;31(16):e251-3. doi: 10.1200/JCO.2012.45.3845. Epub 2013 Apr 8.

引用本文的文献

Immune Checkpoint Inhibitors and Liver Transplantation: Case Report and Review of the Literature.

Clin Case Rep. 2025 Apr 14;13(4):e70412. doi: 10.1002/ccr3.70412. eCollection 2025 Apr.

Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression.

Cancers (Basel). 2024 Sep 4;16(17):3083. doi: 10.3390/cancers16173083.

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies.

Front Transplant. 2023 Oct 30;2:1284740. doi: 10.3389/frtra.2023.1284740. eCollection 2023.

Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT).

Updates Surg. 2024 Jun;76(3):725-741. doi: 10.1007/s13304-024-01845-z. Epub 2024 May 7.

Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion.

World J Gastrointest Surg. 2023 Jan 27;15(1):19-31. doi: 10.4240/wjgs.v15.i1.19.

A Review of the Pharmacokinetic Characteristics of Immune Checkpoint Inhibitors and Their Clinical Impact Factors.

Pharmgenomics Pers Med. 2023 Jan 20;16:29-36. doi: 10.2147/PGPM.S391756. eCollection 2023.

Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge.

Front Med (Lausanne). 2022 Dec 20;9:1014257. doi: 10.3389/fmed.2022.1014257. eCollection 2022.

Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system.

Cancer Med. 2023 Mar;12(5):5181-5194. doi: 10.1002/cam4.5394. Epub 2022 Dec 12.

A Review of Cutaneous Diseases Observed in Solid Organ Transplant Recipients.

J Clin Aesthet Dermatol. 2022 Oct;15(10):21-31.

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma.

World J Gastroenterol. 2022 Sep 14;28(34):4929-4942. doi: 10.3748/wjg.v28.i34.4929.

本文引用的文献

Different regulatory and cytotoxic CD4+ T lymphocyte profiles in renal transplants with antibody-mediated chronic rejection or long-term good graft function.

Transpl Immunol. 2013 Jan;28(1):48-56. doi: 10.1016/j.trim.2012.11.003. Epub 2012 Nov 22.

Melanoma in immunosuppressed patients.

Mayo Clin Proc. 2012 Oct;87(10):991-1003. doi: 10.1016/j.mayocp.2012.04.018.

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

N Engl J Med. 2011 Jun 30;364(26):2517-26. doi: 10.1056/NEJMoa1104621. Epub 2011 Jun 5.

Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Immunol Rev. 2011 May;241(1):180-205. doi: 10.1111/j.1600-065X.2011.01011.x.

Improved survival with ipilimumab in patients with metastatic melanoma.

N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5.

Melanoma in solid organ transplant recipients.

Am J Transplant. 2010 May;10(5):1297-304. doi: 10.1111/j.1600-6143.2010.03078.x. Epub 2010 Mar 26.

Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.

Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x.

Outcomes of melanoma in recipients of solid organ transplant.

J Am Acad Dermatol. 2008 Sep;59(3):405-17. doi: 10.1016/j.jaad.2008.05.015. Epub 2008 Jun 16.

Tregs and rethinking cancer immunotherapy.

J Clin Invest. 2007 May;117(5):1167-74. doi: 10.1172/JCI31202.

The B7-CD28 superfamily.

Nat Rev Immunol. 2002 Feb;2(2):116-26. doi: 10.1038/nri727.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.

J Clin Oncol. 2014 Jul 1;32(19):e69-71. doi: 10.1200/JCO.2013.49.2314. Epub 2014 Feb 3.

What is the role of chemotherapy in the treatment of melanoma?

Curr Treat Options Oncol. 2014 Jun;15(2):321-35. doi: 10.1007/s11864-014-0277-5.

Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma.

Oncol Res Treat. 2014;37(12):757-60. doi: 10.1159/000368316. Epub 2014 Oct 30.

Ipilimumab in cancer patients: the issue of early metabolic response.

Anticancer Drugs. 2013 Mar;24(3):324-6. doi: 10.1097/CAD.0b013e32835dbaaf.

[Metastatic malignant melanoma. Successfull treatment with ipilimumab].

Hautarzt. 2013 Apr;64(4):228, 230-1. doi: 10.1007/s00105-013-2557-6.

Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient.

Eur J Cancer. 2016 Nov;67:66-72. doi: 10.1016/j.ejca.2016.07.026. Epub 2016 Sep 8.

Unusual diffuse liver F-FDG uptake in melanoma patient treated by ipilimumab.

Hell J Nucl Med. 2017 May-Aug;20(2):179-181. doi: 10.1967/s002449910562. Epub 2017 Jul 12.

Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.

J Clin Oncol. 2015 Jun 10;33(17):1873-7. doi: 10.1200/JCO.2014.60.1807. Epub 2015 May 11.

Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases.

Clin Exp Dermatol. 2013 Apr;38(3):276-9. doi: 10.1111/j.1365-2230.2012.04452.x. Epub 2012 Oct 1.

Vemurafenib as neoadjuvant treatment for unresectable regional metastatic melanoma.

J Clin Oncol. 2013 Jun 1;31(16):e251-3. doi: 10.1200/JCO.2012.45.3845. Epub 2013 Apr 8.

引用本文的文献

Immune Checkpoint Inhibitors and Liver Transplantation: Case Report and Review of the Literature.

Clin Case Rep. 2025 Apr 14;13(4):e70412. doi: 10.1002/ccr3.70412. eCollection 2025 Apr.

Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression.

Cancers (Basel). 2024 Sep 4;16(17):3083. doi: 10.3390/cancers16173083.

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies.

Front Transplant. 2023 Oct 30;2:1284740. doi: 10.3389/frtra.2023.1284740. eCollection 2023.

Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT).

Updates Surg. 2024 Jun;76(3):725-741. doi: 10.1007/s13304-024-01845-z. Epub 2024 May 7.

Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion.

World J Gastrointest Surg. 2023 Jan 27;15(1):19-31. doi: 10.4240/wjgs.v15.i1.19.

A Review of the Pharmacokinetic Characteristics of Immune Checkpoint Inhibitors and Their Clinical Impact Factors.

Pharmgenomics Pers Med. 2023 Jan 20;16:29-36. doi: 10.2147/PGPM.S391756. eCollection 2023.

Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge.

Front Med (Lausanne). 2022 Dec 20;9:1014257. doi: 10.3389/fmed.2022.1014257. eCollection 2022.

Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system.

Cancer Med. 2023 Mar;12(5):5181-5194. doi: 10.1002/cam4.5394. Epub 2022 Dec 12.

A Review of Cutaneous Diseases Observed in Solid Organ Transplant Recipients.

J Clin Aesthet Dermatol. 2022 Oct;15(10):21-31.

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma.

World J Gastroenterol. 2022 Sep 14;28(34):4929-4942. doi: 10.3748/wjg.v28.i34.4929.

本文引用的文献

Different regulatory and cytotoxic CD4+ T lymphocyte profiles in renal transplants with antibody-mediated chronic rejection or long-term good graft function.

Transpl Immunol. 2013 Jan;28(1):48-56. doi: 10.1016/j.trim.2012.11.003. Epub 2012 Nov 22.

Melanoma in immunosuppressed patients.

Mayo Clin Proc. 2012 Oct;87(10):991-1003. doi: 10.1016/j.mayocp.2012.04.018.

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

N Engl J Med. 2011 Jun 30;364(26):2517-26. doi: 10.1056/NEJMoa1104621. Epub 2011 Jun 5.

Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Immunol Rev. 2011 May;241(1):180-205. doi: 10.1111/j.1600-065X.2011.01011.x.

Improved survival with ipilimumab in patients with metastatic melanoma.

N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5.

Melanoma in solid organ transplant recipients.

Am J Transplant. 2010 May;10(5):1297-304. doi: 10.1111/j.1600-6143.2010.03078.x. Epub 2010 Mar 26.

Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.

Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x.

Outcomes of melanoma in recipients of solid organ transplant.

J Am Acad Dermatol. 2008 Sep;59(3):405-17. doi: 10.1016/j.jaad.2008.05.015. Epub 2008 Jun 16.

Tregs and rethinking cancer immunotherapy.

J Clin Invest. 2007 May;117(5):1167-74. doi: 10.1172/JCI31202.

The B7-CD28 superfamily.

Nat Rev Immunol. 2002 Feb;2(2):116-26. doi: 10.1038/nri727.